Literature DB >> 10090484

Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations. Mutations in brief no. 226. Online.

M Ebhardt1, H Schmidt, T Doerk, U Tietge, R Haas, M P Manns, J Schmidtke, M Stuhrmann.   

Abstract

In order to obtain a survey of the mutations being prevalent in Northern Germany and to enable molecular genetic testing for families with clinically diagnosed familial hypercholesterolemia (FH), we screened 46 unrelated German individuals with elevated LDL levels for mutations in the 18 exons and their flanking intron sequences including the promotor region of the LDL receptor (LDLR) gene. In addition, we tested all patients for the presence of mutations in the gene coding for apolipoprotein B-100 (apoB-100). We detected 15 mutations affecting the LDLR gene, 8 of which, designated A29S, 195insAT, 313+1insG, 553insG, 680insGGACAAATCTG, D200N, E267K and L411V have not yet been reported. One patient is heterozygous for the double mutant N543H and 2393del9Bp. Two patients carried the mutation R3500Q (Arg-->Glu) within the apoB-100 gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090484     DOI: 10.1002/(SICI)1098-1004(1999)13:3<257::AID-HUMU15>3.0.CO;2-A

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  3 in total

1.  New contributions to the study of common double mutants in the human LDL receptor gene.

Authors:  M Teresa Tejedor; Ana Cenarro; Diego Tejedor; Marianne Stef; Lourdes Palacios; Isabel de Castro; Angel L García-Otín; Luis V Monteagudo; Fernando Civeira; Miguel Pocovi
Journal:  Naturwissenschaften       Date:  2011-09-21

2.  Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia.

Authors:  László Madar; Lilla Juhász; Zsuzsanna Szűcs; Lóránt Kerkovits; Mariann Harangi; István Balogh
Journal:  Genes (Basel)       Date:  2022-01-15       Impact factor: 4.096

3.  Compound Heterozygous Familial Hypercholesterolemia Caused by LDLR Variants.

Authors:  Heloisa Pamplona-Cunha; Marcela Freitas Medeiros; Thaís Cristine Marques Sincero; Isabela de Carlos Back; Edson Luiz da Silva
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.